Benitec Biopharma's total assets for Q1 2026 were $96.03M, a decrease of -3.58% from the previous quarter. BNTC total liabilities were $2.43M for the fiscal quarter, a 5.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.